Treatment and experimental procedures
A solution of 1, 2-dimethylhydrazine dihydro chloride (DMH; Aldrich Chemical, Milwaukee, Wis., USA) was prepared in a 0.9% saline solution that contained 1.5% EDTA (Nacalai Tesque, Kyoto, Japan) and was adjusted to pH 6.5 with 4% NaOH. The solution was always freshly prepared just before use. Animals were given weekly s.c. injections in the back, beginning at 6 weeks of age. Fifteen shrews were given 14 weekly doses of 40 mg/kg body weight (group 1), and another 15 animals were given 28 weekly doses of 20mg/kg body weight. Injections were stopped at the 14th injection in group 1 due to the death of two experi mental animals during the week before the 14th injection, and we also stopped at the 28th injection in group 2 to adjust the total dose of DMH (560 mg/kg/shrew).
Five animals that received no injections served as controls (Group 3). Shrews were weighed weekly until the termination of the experiment (60 weeks of age). The animals were sacrificed when they became moribund, when tumors were visible, or when they reached 60 weeks of age. The number of viable shrews was taken to be the number that survived until the end of DMH administration. 
Results
The increases in body weight in the DMH -treated and control shrews were comparable, and the animals showed no acute toxicity after DMH treatment. In addition to the two shrews that died in group 1, two animals each in groups 1 and 2 died after the carcinogen treatment was completed; however, as no histopathological examination could be made due to cannibalism, they were excluded from the calculation.
Therefore, as shown in Table 1 , the numbers of viable shrews were 11 in group 1 and 13 in group 2. Tumors developed in DMH-injected aimals, whereas in the 5 control shrews, no tumors were seen when they were sacrificed at 60 weeks of age when the experi ment was terminated.
The mean age when killed was 55.9 weeks in group 1 animals and 53.1 weeks in group 2. All these animals exhibited similar tumor induction, so that the following descriptions apply to both groups. Musk gland tumors, usu ally bilateral, were induced in 9 animals in group 1 (82%), and in 12 in group 2 (92%) between 36 and 60 weeks of age. Microscopically, the musk gland tumors, which were multilobular, were sharply circumscribed, and they often exhibited ulceration and bleeding (Figs. 1 and 2) . In some tumor cell nests, they were rimmed by basaloid cells and fully developed sebocytes were seen near the center (sebaceous adenoma) (Fig. 3) , this often being accompanied by holocrine secretion. Other tumor cell nests consisted of basaloid cells only (sebaceous epithelioma) (Fig. 4) . Mitosis was seen, but the lack of local invasion indicated its benign nature.
Besides the musk gland tumors, the DMH -treated shrews developed leukemia1, liver adenoma1, pulmonary adenoma1, and intestinal tumors2. The leukemia developed in a 50-week -old shrew showing splenomegaly and was lymphoblastic in type. The pulmonary adenoma and liver cell adenoma occurred in shrews that were 50 and 60 weeks of age, respectively. In general, the livers of the DMH-treated shrews showed signs of toxic damage. Although mitosis was not seen, variable shapes of hepatocytes (megalocytes) with enlarged nuclei were observed (Fig. 5) . Additionally, the liver parenchymal cells became progressively less PAS-positive, in dicating loss of glycogen storage. During the experiment, no diarrhea or rectal bleeding was seen. Although we observed two carcinomas originating in the small intestine (Fig. 6) , no macroscopic or microscopic alterations were found in the colons of DMH-treated shrews. No metas tasis was observed in any of these tumor-bearing shrews within the experimental period.
Discussion
This study showed that a high incidence of musk gland tumors was induced in female shrews by DMH injection. Musk gland tumors are an drogen-dependent and contain androgen receptors14. It is interesting to note that the in duced tumors were restricted to the musk glands and that no tumors developed in the cutaneous pilosebaceous glands. Although the spontaneous occurrence of pilosebaceous tumors is frequently seen in male shrews, these tumors are rarely seen in females. This remarkable sexual dimorphism indicates that male sex hormones may favor the development of these tumors3. Sebaceous tumors have been experimentally induced in rats exposed to various carcinogens8,15-17, e.g., DMBA, DMH and its metabolites such as azoxymethane (AOM), the tumors usually being localized in the sebaceous glands of the ear ducts.
In previous studies of shrews, a high incidence of leukemia and pulmonary tumors was seen after DMBA and BHA administration, respectively 4.6.7. In the present study, we found that DMH also evoked these tumors but at a much lower inci dence. DMH had toxic effects on the liver; simi lar toxic effects have been observed in rats8, mice10, and hamsters13, wherein hepatocytes became great ly enlarged and exhibited pleomorphic nuclei (megalocytes). Adenoma of the liver was induced in one shrew, this being similar to that reported to be induced in rats by AOM16 
